inTouch·diabetes Cleared by the U.S. Food and Drug Administration

Advanced, Comprehensive Wireless Diabetes Management System Has Potential to
Impact Outcomes and Lower Costs
WEST CHESTER, Pa.--(Business Wire)--
SymCare Personalized Health Solutions, Inc., announced today that the FDA has
cleared the new inTouch·diabetes program to support effective diabetes
management. The new web-based system uses a combination of objective biometric
data, education and a rewards program to better engage patients in effective
diabetes management.

inTouch·diabetes combines patient-centered decision-making with state-of-the-art
health information technology. This FDA-cleared system offers patients a network
of support and customized education and information while providing healthcare
professionals with objective biometric data for more specific and personalized
patient/healthcare professional interaction.

Features of inTouch·diabetes:

* Individualized program - goes beyond recording daily blood glucose levels by
showing trends, providing diabetes education and supplying other relevant
information
* Enhanced technology - automatically collects blood sugar readings from a
glucose meter and wirelessly transmits them to a secure web site, allowing
patients and caregivers to identify trends. Also enables text messaging to cell
phones for on-the-go management
* Privacy - SymCare Personalized Health Solutions, Inc. is committed to
maintaining the confidentiality, integrity and security of personal information
* Coaches - offer live one-on-one discussions about information that patients
can discuss with their healthcare providers
* Personalized education - provides content from Johns Hopkins University and
diet and exercise programs from e-Diets to encourage conversations between
patients and their healthcare team
* Positive reinforcement - a rewards program linked to AMAZON.COM® that can lead
to behavioral changes and improved outcomes

About SymCare Personalized Health Solutions, Inc.

SymCare Personalized Health Solutions, Inc. is committed to enhancing prevention
and treatment in chronic populations through the support of new models of care.
For additional information, visit www.symcare.com.

SymCare Personalized Health Solutions, Inc.
Melissa Katz, 215-514-0957
Mkatz2@its.jnj.com

Copyright Business Wire 2009